Senior leaders in the Environmental Protection Agency’s Office of Chemical Safety and Pollution Prevention altered or omitted key evidence in approving dicamba for use in 2018, leading to a federal appeal court’s vacating of the registrations, according to the agency's internal watchdog.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.